Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This term describes a biological process in which host cells express pathogen-derived antigens (via genetic material or recombinant proteins), leading to their presentation on MHC molecules and activation of the adaptive immune system. This mechanism underlies modern vaccination strategies such as mRNA vaccines, viral vector vaccines, and some investigational cancer immunotherapies. When endogenous expression of antigens occurs, either through infection or via gene-based vaccination, professional antigen-presenting cells present these antigens to T and B lymphocytes, resulting in antigen-specific immunological memory and robust adaptive immune responses upon subsequent exposures[1][2][3][6].
Endogenous production of pathogen-specific antigens in host cells, leading to antigen presentation via MHC molecules and activation of T cells, with subsequent adaptive immune responses[2][6]. Induction of immunological memory through clonal expansion of antigen-specific B and T cells[1][5][6].
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on null.